BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 17349957)

  • 41. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response.
    Kummer JA; Broekhuizen R; Everett H; Agostini L; Kuijk L; Martinon F; van Bruggen R; Tschopp J
    J Histochem Cytochem; 2007 May; 55(5):443-52. PubMed ID: 17164409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptor protein controlled oligomerization activates the AAA+ protein ClpC.
    Kirstein J; Schlothauer T; Dougan DA; Lilie H; Tischendorf G; Mogk A; Bukau B; Turgay K
    EMBO J; 2006 Apr; 25(7):1481-91. PubMed ID: 16525504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation.
    Fernandes-Alnemri T; Wu J; Yu JW; Datta P; Miller B; Jankowski W; Rosenberg S; Zhang J; Alnemri ES
    Cell Death Differ; 2007 Sep; 14(9):1590-604. PubMed ID: 17599095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Biophysical Characterisation and SAXS Analysis of Human NLRP1 Uncover a New Level of Complexity of NLR Proteins.
    Martino L; Holland L; Christodoulou E; Kunzelmann S; Esposito D; Rittinger K
    PLoS One; 2016; 11(10):e0164662. PubMed ID: 27727326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival.
    Gurcel L; Abrami L; Girardin S; Tschopp J; van der Goot FG
    Cell; 2006 Sep; 126(6):1135-45. PubMed ID: 16990137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Regulation of cytokine production in inflammatory bowel disease].
    Ferrero-Miliani L; Seidelin JB; Nielsen OH
    Ugeskr Laeger; 2006 May; 168(19):1847-50. PubMed ID: 16756799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NACHT-LRR proteins (NLRs) in bacterial infection and immunity.
    Kufer TA; Fritz JH; Philpott DJ
    Trends Microbiol; 2005 Aug; 13(8):381-8. PubMed ID: 15994078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caspase-1 builds a new barrier to infection.
    Saleh M
    Cell; 2006 Sep; 126(6):1028-30. PubMed ID: 16990128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential Peptidoglycan Recognition Assay Using Varied Surface Presentations.
    D'Ambrosio EA; Bersch KL; Lauro ML; Grimes CL
    J Am Chem Soc; 2020 Jun; 142(25):10926-10930. PubMed ID: 32520538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Consensus design of a NOD receptor leucine rich repeat domain with binding affinity for a muramyl dipeptide, a bacterial cell wall fragment.
    Parker R; Mercedes-Camacho A; Grove TZ
    Protein Sci; 2014 Jun; 23(6):790-800. PubMed ID: 24659515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing ATP binding and hydrolysis by NLR proteins.
    Mo J; Duncan JA
    Methods Mol Biol; 2013; 1040():153-68. PubMed ID: 23852603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders.
    Taïeb A
    Pigment Cell Res; 2007 Aug; 20(4):260-2. PubMed ID: 17630958
    [No Abstract]   [Full Text] [Related]  

  • 53. Innate immunity: Caspase 8 prevents inflammasome activation.
    Papatriantafyllou M
    Nat Rev Immunol; 2013 Feb; 13(2):68-9. PubMed ID: 23334248
    [No Abstract]   [Full Text] [Related]  

  • 54. The NLRP1 inflammasomes.
    Chavarría-Smith J; Vance RE
    Immunol Rev; 2015 May; 265(1):22-34. PubMed ID: 25879281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inflammasomes.
    Schroder K; Tschopp J
    Cell; 2010 Mar; 140(6):821-32. PubMed ID: 20303873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-canonical inflammasome activation targets caspase-11.
    Kayagaki N; Warming S; Lamkanfi M; Vande Walle L; Louie S; Dong J; Newton K; Qu Y; Liu J; Heldens S; Zhang J; Lee WP; Roose-Girma M; Dixit VM
    Nature; 2011 Oct; 479(7371):117-21. PubMed ID: 22002608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reconstituting the NLRP1 inflammasome in vitro.
    Faustin B; Reed JC
    Methods Mol Biol; 2013; 1040():137-52. PubMed ID: 23852602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.
    Bauernfeind FG; Horvath G; Stutz A; Alnemri ES; MacDonald K; Speert D; Fernandes-Alnemri T; Wu J; Monks BG; Fitzgerald KA; Hornung V; Latz E
    J Immunol; 2009 Jul; 183(2):787-91. PubMed ID: 19570822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.
    Hsu LC; Ali SR; McGillivray S; Tseng PH; Mariathasan S; Humke EW; Eckmann L; Powell JJ; Nizet V; Dixit VM; Karin M
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7803-8. PubMed ID: 18511561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells.
    Masters SL; Gerlic M; Metcalf D; Preston S; Pellegrini M; O'Donnell JA; McArthur K; Baldwin TM; Chevrier S; Nowell CJ; Cengia LH; Henley KJ; Collinge JE; Kastner DL; Feigenbaum L; Hilton DJ; Alexander WS; Kile BT; Croker BA
    Immunity; 2012 Dec; 37(6):1009-23. PubMed ID: 23219391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.